{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:27:39Z","timestamp":1752982059252},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.encep.2008.06.019","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T04:22:38Z","timestamp":1231474958000},"page":"496-498","source":"Crossref","is-referenced-by-count":4,"title":["Syndrome parkinsonien sous aripiprazole\u00a0: \u00e0 propos d\u2019un cas"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Pasquier de Franclieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Germain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Petitjean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2008.06.019_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.encep.2008.06.019_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacocinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.encep.2008.06.019_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4088\/JCP.v66n0118c","article-title":"Extrapyramidal side effects associated with aripiprazole coprescription in two patients","volume":"66","author":"Cohen","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2008.06.019_bib4","series-title":"\u00c9valuation clinique standardis\u00e9e en psychiatrie","article-title":"Impressions cliniques globales CGI","author":"Frenckell","year":"1996"},{"key":"10.1016\/j.encep.2008.06.019_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2165\/00003495-200464150-00010","article-title":"Aripiprazole: a review of its use in schizophrenia and affective disorder","volume":"64","author":"Harrison","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.encep.2008.06.019_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1993.146","article-title":"Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects","volume":"54","author":"Huang","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.encep.2008.06.019_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2008.06.019_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Kane","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2008.06.019_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/01.chi.0000095540.18151.b0","article-title":"Aripiprazole and extrapyramidal symptoms","volume":"42","author":"Lindsey","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.encep.2008.06.019_bib10","first-page":"S176","article-title":"Aripiprazole: a dopamine-serotonin system stabilizer","volume":"5","author":"McQuade","year":"2002","journal-title":"Int J Neuropsychopharm"},{"key":"10.1016\/j.encep.2008.06.019_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2146\/ajhp060209","article-title":"Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities","volume":"64","author":"Brahm","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.encep.2008.06.019_bib12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0269881106060194","article-title":"A case of aripiprazole and extrapyramidal side effects","volume":"20","author":"Salmoiraghi","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.encep.2008.06.019_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00008571-200204000-00008","article-title":"Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study","volume":"12","author":"Schillevoort","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.encep.2008.06.019_bib14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1542\/peds.2004-1268","article-title":"Severe extrapyramidal symptoms in a 3-year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole","volume":"114","author":"Schonberger","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.encep.2008.06.019_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.yic.0000185025.40656.30","article-title":"Aripiprazole-induced parkinsonism","volume":"21","author":"Sharma","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2008.06.019_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1440-1614.2006.01774_3.x","article-title":"Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder","volume":"40","author":"Ziegenbein","year":"2006","journal-title":"Aust N Z J Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700608002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700608002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T14:00:04Z","timestamp":1545487204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700608002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0013700608002686"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2008.06.019","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}